With a history that’s over a century in the making, beginning in 1893 when founder, Elliott P. Joslin, MD, first developed his interest in diabetes care, Joslin Diabetes Center today is the largest institution in the world devoted exclusively to diabetes research, care, and education.

When you walk through Joslin Diabetes Center, you'll find researchers, physicians, clinicians, and educators — all focused on improving the lives of people with diabetes. Over the years, important discoveries have been made at Joslin, lives have been changed, and our Center has earned global recognition for diabetes research and care.

Mr. Brijendra Singh
Sr. VP Lupin Ltd.
Sales and Marketing

Dear Doctors,

My heartfelt greetings to all of you!

I sincerely thank and acknowledge each one of you for participating in ISD 2022. With ISD 2023, this scientific grandeur has become the epitome of our mutual passion in the effective combat of diabetes across the country.

The burden of diabetes is increasing rapidly in India. At Lupin, we continue to extend our support to the medical fraternity to battle this threat by providing all the necessary medications in every nook and corner of the country.

Lupin’s strong belief in its vision, "To be an innovation led Transnational Pharmaceutical Company” has bought us a long way since its inception. Since our foundation, we at Lupin have been striving to fight the deadly disease of Diabetes. India is home to over 77 million diabetics, representing 17% of the total number of diabetes patients in the world. As it is among the top 10 leading causes of mortality, it is necessary to focus on strengthening our endeavour in the management of Diabetes. In order to achieve this, we have added value through our range of quality & innovative products for Indian patients.

It gives me great pleasure to invite you to our International Symposia on Diabetes (ISD) 2023 in partnership with Joslin Diabetes Center. As you know since its inception, ISD mirrors all cutting-edge research, advancements and new treatments in Diabetes. This conference provides a platform for networking with the world’s leading experts from Joslin Diabetes Center, focusing on reviewing and assessing best practices in the management of Diabetes.

ISD sees a conglomeration of more than 1000 eminent clinicians discussing related issues in Diabetes management while exploring all possible options for providing better care.

ISD 2023 is set to host preeminent innovators from Joslin Diabetes Center as the international faculty. With their rich experience and expertise in diabetes research & practice, this platform enables you to interact with global thought leaders in the field of Diabetes Management.

At Lupin, we always cherish your association in all our scientific endeavours dedicated for achieving better treatment outcomes for patients and improving the quality of their lives through knowledge and skill enhancement.

We look forward to welcoming you to the forthcoming ISD 2023.